Stephen Rocamboli

Stephen Rocamboli

Directeur/Membre du Conseil chez
Cortice Biosciences, Inc.

Fortune : 216 787 $ au 31/05/2026

54 ans
Health Technology
Finance
Commercial Services

Profil

Stephen Charles Rocamboli was the founder of Pear Tree Pharmaceuticals, Inc., founded in 2008, where the titles held included President & Secretary from 2008 to 2018.
Current jobs include Director at Cortice Biosciences, Inc. and Director at Androvia Life Sciences.
Former jobs include Chairman & Chief Executive Officer at Perla Therapeutics, Inc.; Non-Executive Chairman & Secretary at VioQuest Pharmaceuticals, Inc. from 2003 to 2009; Senior Managing Director & General Counsel at Paramount BioCapital, Inc. from 2004 to 2007; Director at Cutanea Life Sciences, Inc.; Director at Foresight Biotherapeutics, Inc.; Independent Director at TFF Pharmaceuticals, Inc. from 2018 to 2024; Independent Director at Esperion Therapeutics, Inc. from 2022 to 2026; President & Secretary at Chitina Sciences, Inc. in 2007; President & Secretary at Cordova Sciences, Inc.; Special Counsel at Wyrick Robbins Yates & Ponton LLP from 2014 to 2015; Partner at Orion Biomedical Fund LP from 1999 to 2007; Deputy General Counsel at Paramount BioSciences LLC from 1999 to 2004; Secretary & Chief Business Officer at Candel Therapeutics, Inc. from 2015 to 2020; General Partner at Integrin Partners LLC from 2010 to 2015; and Partner at Beijing International Group LLC from 2010 to 2012.
Education includes undergraduate studies at State University of New York at Albany and graduate studies at Fordham University School of Law.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/05/2026 69 261 ( 0,03 % ) 216 787 $ 31/05/2026

Postes actifs de Stephen Rocamboli

SociétésPosteDébut
Directeur/Membre du Conseil -
Androvia Life Sciences
Directeur/Membre du Conseil -

Anciens postes connus de Stephen Rocamboli

SociétésPosteFin
ESPERION THERAPEUTICS, INC. Directeur/Membre du Conseil 28/05/2026
TFF PHARMACEUTICALS, INC. Directeur/Membre du Conseil 14/11/2024
CANDEL THERAPEUTICS, INC. Conseiller Juridique Général 01/05/2020
Fondateur 01/05/2018
Corporate Officer/Principal 01/04/2015
Voir l'expérience en détail de Stephen Rocamboli

Formation de Stephen Rocamboli

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

37

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Health Technology

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Orion Biomedical Fund LP

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Beijing International Group LLC

Androvia Life Sciences

Perla Therapeutics, Inc.

  1. Bourse
  2. Insiders
  3. Stephen Rocamboli
🔇